A new class of safe oligosaccharide polymer therapy to modify the mucus barrier of chronic respiratory disease
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 5 - Biological Sciences
- Output identifier
- 101558528
- Type
- D - Journal article
- DOI
-
10.1021/acs.molpharmaceut.5b00794
- Title of journal
- Molecular Pharmaceutics
- Article number
- -
- First page
- 863
- Volume
- 13
- Issue
- 3
- ISSN
- 1543-8384
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
http://dx.doi.org/10.1021/acs.molpharmaceut.5b00794
- Supplementary information
-
https://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.5b00794/suppl_file/mp5b00794_si_001.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
18
- Research group(s)
-
-
- Citation count
- 31
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- a) The author made a substantial contribution to carrying out the study; b) The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -